Phapros Tbk.
Hub Segmentasi: Analisis Fundamental Umum (General Hub)
Tingkat pengembalian modal yang diinvestasikan. Nilai > 12% menunjukkan alokasi modal...
Mendeteksi kualitas laba bersih. Rasio di luar rentang -10% s/d 10% mengindikasikan l...
Rasio total utang terhadap modal ekuitas bersih.
Diagnosis Kesimpulan Sektor
Kinerja fundamental stabil, namun perhatikan tingkat margin laba bersih operasional dan rasio utang ekuitas.
Emiten teratas dalam sektor Healthcare
PT Phapros Tbk, together with its subsidiaries, operates in the pharmaceutical industry in Indonesia. The company operates through Ethical; Over the Counter (OTC) Drugs; Generic Drugs Bearing (OCB); and Toll-in segments. It offers OTC drugs, including Antimo Anak, Antimo tablet, Livron B Plex, Becefort Sirop and tablet, Noza, Febrinex, Betafort suspensi, and Hemorogard. The company also provides ethical generic and branded products; and medical devices, as well as toll manufacturing. It also exports its products. The company was founded in 1954 and is headquartered in Jakarta Selatan, Indonesia. PT Phapros Tbk is a subsidiary of PT Kimia Farma Tbk.
Beginner Insight:Understanding the "Architecture" helps you verify the company's physical scale and legitimacy. A global workforce usually indicates a mature, institutional player.